Physician profile
Samir Patel
NPI 1760611032
$873.40
in general payments reported to CMS, 2019-2025
11 companies · $174 in 2025
The $174 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $232 · 2020: $13.84 · 2021: $99.52 · 2022: $81.86 · 2023: $127 · 2024: $145 · 2025: $174.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $446.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $446.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $213.65 | 2019-2024 | Augment Injectable, Ortholoc 2 Lapifuse |
| Smith+Nephew, INC. | $170.80 | 2019-2025 | Stravix |
| Abbvie INC. | $154.13 | 2022-2024 | |
| Kerecis Limited | $123.92 | 2022-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Graftguide |
| Paratek Pharmaceuticals, INC. | $64.20 | 2023-2025 | Nuzyra |
| Melinta Therapeutics, LLC | $41.51 | 2019 | |
| Solventum Corporation | $37.42 | 2025 | Promogran Prisma, Activ.A.C. |
| Zimvie INC. | $23.26 | 2024 | |
| Urgo Medical North America, LLC | $16.01 | 2023 | Urgok2 |
| Arbor Pharmaceuticals, INC. | $14.66 | 2021 | |
| Horizon Therapeutics Plc | $13.84 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Samir Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.